Zoetis (NY:<a title="Quote for Zoetis" href="https://markets.financialcontent.com/spoke/quote?Symbol=NY%3AZTS">ZTS )

Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

March 12, 2026

From Zoetis Inc.

Their futures look bright, and their dividends are safe.

2 No-Brainer Dividend Stocks to Buy in 2026 ↗

March 08, 2026

Topics Intellectual Property

Zoetis to Participate in Upcoming Investor Conferences

March 05, 2026

From Zoetis Inc.

USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier

ZOETIS INC (NYSE:ZTS): A Durable Dividend Stock for Quality-Focused Income Investors ↗

February 28, 2026

Via Chartmill

Zoetis Inc. (NYSE:ZTS) Reports Q4 Earnings Beat and Steady 2026 Guidance ↗

February 12, 2026

Via Chartmill

Topics Earnings

Zoetis Inc. (NYSE:ZTS): A Dependable Dividend Stock Built on Financial Strength ↗

January 31, 2026

Via Chartmill

March 02, 2026

The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that...

Via MarketMinute

Topics Economy

Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

March 02, 2026

From Zoetis Inc.

Over the last six months, Zoetis’s shares have sunk to $129.91, producing a disappointing 16.4% loss - a stark contrast to the S&P 500’s 7.2% gain. This may have investors wondering how to approach the...

2 Reasons to Like ZTS (and 1 Not So Much)

February 26, 2026

Topics Stocks

Zoetis Inc (NYSE:ZTS) Passes Key Quality Investing Screen ↗

January 24, 2026

Via Chartmill

Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

February 24, 2026

From Zoetis Inc.

These two healthcare stocks are likely headed higher from their current prices.

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200 ↗

February 22, 2026

Zoetis’ fourth quarter results were met with a muted market reaction, as headwinds in the U.S. companion animal segment and margin pressures offset revenue growth. Management pointed to lingering...

The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

February 19, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Topics Earnings

2 S&P 500 Stocks to Research Further and 1 We Question

February 16, 2026

The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for...

Topics Stocks

3 S&P 500 Stocks Worth Investigating

February 15, 2026

Animal health company Zoetis (NYSE:ZTS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue...

Topics Stocks

ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook

February 13, 2026

Animal health firm Zoetis Inc. (NYSE: ZTS) reports Q4 2025 earnings, with adjusted EPS of $1.48 beating consensus of $1.40.

Analysts Question Zoetis' Pathway To Growth As Key Segments Slide ↗

February 12, 2026

Via Benzinga

Zoetis (ZTS) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

Zoetis (ZTS) Q4 2025 Earnings Call Transcript

Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,...

Topics Bonds Earnings

Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market

February 12, 2026

Via Finterra

Topics Artificial Intelligence Earnings Economy

Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates

February 12, 2026

Animal health company Zoetis (NYSE:ZTS) announced better-than-expected revenue in Q4 CY2025, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue to be around...

Zoetis Reports Fourth Quarter and Full Year 2025 Results

February 12, 2026

From Zoetis Inc.

Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Thursday morning. Here’s what to expect.

Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 10, 2026

After walking back guidance last quarter, could this animal health company reveal surprises come earnings day?

Topics Artificial Intelligence

Should You Buy Zoetis Before Feb. 12? ↗

February 09, 2026

Topics Earnings

Zoetis Declares Second Quarter 2026 Dividend

February 05, 2026

From Zoetis Inc.

USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border

February 05, 2026

In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...

Via MarketMinute

Topics Death Economy

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

February 01, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Don't wait too long to press the buy button on these comeback stories.

2 Healthcare Stocks Poised for a Comeback in 2026 ↗

January 22, 2026

This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years ↗

January 22, 2026

Trading at a once-in-a-decade low valuation, this leading animal healthcare stock deserves a long look from investors.

Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

January 20, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with...